Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Antibody-dependent cellular phagocytosis of tropomyosin receptor kinase C (TrkC) expressing cancer cells for targeted immunotherapy

Cancer Immunology Immunotherapy(2022)10.1007/s00262-022-03147-ySource: DataRank Database

Antibody-dependent cellular phagocytosis of tropomyosin receptor kinase C (TrkC) expressing cancer cells for targeted immunotherapy is a research paper published in Cancer Immunology Immunotherapy (2022). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.30)OA: greenTopics (51)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Syed Muhammad Usama ORCID,Lik Voon Kiew ORCID,Hong Boon Lee ORCID,Lip Yong Chung ORCID,Kevin Burgess ORCID

Live enrichment

PubMed:35032175 PMC:PMC10365225 OpenAlex:https://openalex.org/W4206063147

Majlis Kanser Nasional

Grant: Cancer Research Award (CRA) 2017

Skim Geran Penyelidikan Fundamental

Grant: FRGS/1/2020/SKK0/MSU/02/1

National Institutes of Health

Grant: NIH R01EY029645

Texas A and M University

Grant: T3-Grants Program (246292-00000).

NEI NIH HHS

Grant: R01 EY029695

FWCI

0.30

Citation Percentile

0.5%

Citation Trend

2022

2025

greenLicense: https://www.springer.com/tdm

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10365225/pdf/262_2022_Article_3147.pdf

GREENhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10365225

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10365225/pdf/262_2022_Article_3147.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s00262-022-03147-y.pdf

publisherhttps://link.springer.com/article/10.1007/s00262-022-03147-y/fulltext.html

Fields of Study

Phagocytosis and Immune RegulationMonoclonal and Polyclonal Antibodies ResearchAdenosine and Purinergic SignalingMedicineBiologyAnimalsAntibodiesAntibody FormationAntigensCarrier ProteinsDipeptidesHaptensImmunologic FactorsImmunotherapyMiceNeoplasm Recurrence, LocalPhagocytosisTropomyosin

MeSH Terms

AnimalsAntibodiesAntibody FormationAntigensCarrier ProteinsDipeptidesHaptensImmunologic FactorsImmunotherapyNeoplasm Recurrence, LocalPhagocytosisTropomyosinMice

Keywords

Tropomyosin receptor kinase CTropomyosinPhagocytosisCancer immunotherapyAntibodyImmunotherapyCancer researchBiologyReceptorChemistryMolecular biologyImmunologyCell biologyImmune systemBiochemistryTrkCDinitrophenolActive TargetingAntibody-dependent Cellular PhagocytosisLigand-hapten Conjugate

Sustainable Development Goals

SDG 0: Good health and well-being

Antibody-dependent cellular phagocytosis of tropomyosin receptor kinase C (TrkC) expressing cancer cells for targeted immunotherapy

FAIR Checklist

Authors (7)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)